USA - NASDAQ:LFVN - US53222K2050 - Common Stock
The current stock price of LFVN is 6.31 USD. In the past month the price decreased by -28.46%. In the past year, price decreased by -55.56%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 51.55 | 31.21B | ||
| KVUE | KENVUE INC | 15.09 | 30.99B | ||
| ELF | ELF BEAUTY INC | 22.14 | 3.88B | ||
| BRBR | BELLRING BRANDS INC | 13.73 | 3.75B | ||
| COTY | COTY INC-CL A | 16.42 | 2.73B | ||
| IPAR | INTERPARFUMS INC | 15.46 | 2.60B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 6.7 | 790.75M | ||
| OLPX | OLAPLEX HOLDINGS INC | 12.88 | 687.09M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 6.87 | 469.26M | ||
| NATR | NATURES SUNSHINE PRODS INC | 20.98 | 347.86M | ||
| USNA | USANA HEALTH SCIENCES INC | 9.53 | 341.10M | ||
| HNST | HONEST CO INC/THE | 42.17 | 281.51M |
LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. The company is headquartered in Lehi, Utah and currently employs 232 full-time employees. The company went IPO on 2012-09-12. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. The company sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
LIFEVANTAGE CORP
3300 Triumph Blvd, Suite 700
Lehi UTAH 84043 US
CEO: Steven R. Fife
Employees: 222
Phone: 18014329000
LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. The company is headquartered in Lehi, Utah and currently employs 232 full-time employees. The company went IPO on 2012-09-12. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. The company sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
The current stock price of LFVN is 6.31 USD. The price decreased by -1.41% in the last trading session.
LIFEVANTAGE CORP (LFVN) has a dividend yield of 2.78%. The yearly dividend amount is currently 0.17.
LFVN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
LFVN stock is listed on the Nasdaq exchange.
LIFEVANTAGE CORP (LFVN) has a market capitalization of 80.07M USD. This makes LFVN a Micro Cap stock.
You can find the ownership structure of LIFEVANTAGE CORP (LFVN) on the Ownership tab.
ChartMill assigns a fundamental rating of 7 / 10 to LFVN. LFVN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months LFVN reported a non-GAAP Earnings per Share(EPS) of 0.81. The EPS increased by 35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.29% | ||
| ROA | 13.63% | ||
| ROE | 28.3% | ||
| Debt/Equity | 0 |
8 analysts have analysed LFVN and the average price target is 24.48 USD. This implies a price increase of 287.96% is expected in the next year compared to the current price of 6.31.
For the next year, analysts expect an EPS growth of 26.41% and a revenue growth 4.02% for LFVN